- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
This is an old revision of the document!
Table of Contents
News and highlights
Immune Disease and the Microbiome: Healthcare in response to New Knowledge presented by Professor Trevor Marshall to the Predictive, Preventive and Personalized Medicine conference: Moscow, Russia. September 2016
Publications and presentations
| Microbe-Microbe and Host-Microbe Interactions - 2017 paper in Discovery medicine |
| Electrosmog and immune disease - paper in Immunologic research containing new information on immune suppression |
| Inflammatory disease and the human microbiome - paper in Discovery medicine which discusses successive infectionAn infectious cascade of pathogens in which initial infectious agents slow the immune response and make it easier for subsequent infections to proliferate. and methods for reversal of pathogen-induced genomic dysregulation |
| Immunostimulation in the treatment for chronic fatigue syndrome/myalgic encephalomyelitis - paper in Immunologic research which discusses the role of immunostimulation in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis |
| The human microbiome and autoimmunity - paper in Current opinion in rheumatology which reviews the role of chronic pathogens in “autoimmuneA condition or disease thought to arise from an overactive immune response of the body against substances and tissues normally present in the body” conditions |
| Immunostimulation in the era of the metagenome - paper in Cellular & molecular immunology - collaboraton with American and international clinical professionals to research a model-based treatment for inflammatory disease |
About Marshall Protocol Recovery
Due to differences in molecular structure, each ARBA drug which is an angiotensin receptor blocker. One of the ARBs is olmesartan (Benicar). Not all ARBs activate the Vitamin D Receptor. is shown to have significantly different properties when interacting with the nuclear receptorsIntracellular receptor proteins that bind to hydrophobic signal molecules (such as steroid and thyroid hormones) or intracellular metabolites and are thus activated to bind to specific DNA sequences which affect transcription. in the immune cells. For example: where Telmisartan would quickly and completely suppress immune function, frequent dosing of OlmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. over a prolonged period allows recovery of immune function via activation of the vitamin D receptor.
Data collected since 2004 supports the hypothesis that with the addition of diligent avoidance of every form of immune suppression overall health can be maintained and the body restored to natural homeostasis.
About Autoimmunity Research Foundation
Autoimmunity Research Foundation is a California-based non-profit organization formed to conduct scientific research into the cause and cure of autoimmune and non-autoimmune diseases, and to instruct the public on subjects related to disease, useful to individuals and beneficial to the community.
About the MPKB Project
The MPKB currently contains about 400 pages and draws from the best possible evidence to support its mission. As of May 2011, about 85% of those articles are complete with the remainder awaiting completion or revision.